Dr. Jonas Kengne Ouafo is a Postdoctoral Associate at the University of Florida, USA, and a Research Fellow with the Molecular and Computational Cell Biology (MUTATE) Research Group at the Translational Research and Development Foundation (TREND Foundation). His research focuses on understanding the molecular biology, transmission dynamics, and resistance mechanisms of malaria parasites and their mosquito vectors, with the goal of identifying biological markers and vulnerabilities that can inform improved disease control strategies. His work integrates molecular biology, functional genomics, transcriptomics, and computational approaches to investigate parasite–vector interactions and the mechanisms underlying adaptation and resistance. In collaboration with the Centre for Research in Infectious Diseases (CRID-CAM), he recently applied functional genomics approaches to identify genomic loci associated with pyrethroid resistance in Anopheles gambiae, one of the major malaria vectors in Africa. Jonas obtained his Ph.D. in Molecular Cell Biology of Infectious Diseases from the University of Ghana’s West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), supported through a Wellcome Trust/DELTAS fellowship. His doctoral research employed reverse vaccinology and transcriptomic approaches to identify and characterise Plasmodium falciparum genes with potential for transmission-blocking vaccine development. Using RNA sequencing, he investigated stage-specific gene expression patterns between sexual and asexual parasite stages in clinical isolates and laboratory-adapted strains, providing insights into parasite biology and transmission mechanisms. Prior to his doctoral studies, Jonas contributed to multidisciplinary research programmes investigating malaria and filarial diseases, including studies on disease epidemiology, parasite biology, and mechanisms associated with ivermectin resistance in Onchocerca volvulus, the causative agent of river blindness. Through his expertise in parasite genomics, vector biology, and molecular approaches to infectious disease research, Jonas contributes to MUTATE Research Group’s mission of advancing mechanistic understanding of pathogen adaptation and translating biological discoveries into innovative solutions for infectious disease control.